<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04065893</url>
  </required_header>
  <id_info>
    <org_study_id>CRT-Bivent.</org_study_id>
    <nct_id>NCT04065893</nct_id>
  </id_info>
  <brief_title>Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy</brief_title>
  <official_title>Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Köln</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Köln</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac resynchronization therapy reduces mortality in patients with systolic heart failure&#xD;
      and left bundle branch block. Reduced biventricular pacing can lead to therapy failure. Most&#xD;
      effective mortality reduction was seen with a BiV pacing above 98%.&#xD;
&#xD;
      Reduced BiV pacing is a common phenomenon with potential impact on CRT-response and pts'&#xD;
      prognosis. Frequent ventricular ectopy may be associated with attenuated benefit from CRT.&#xD;
      The investigators sought to systematically assess the effect of ventricular arrhythmia&#xD;
      treatment on BiV pacing.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Actual">August 1, 2021</completion_date>
  <primary_completion_date type="Actual">August 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Biventricular pacing</measure>
    <time_frame>3 month after intervention biventricular pacing (%) is routinely monitored</time_frame>
    <description>Influence of intervention (Ablation/medical treatment) on previously reduced biventricular pacing percentage (&lt;98%). Biventricular pacing is measured in percentage of stimulation and is monitored at routine device interrogation.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">65</enrollment>
  <condition>Systolic Heart Failure</condition>
  <condition>Ventricular Premature Complexes</condition>
  <condition>Ventricular Tachycardia</condition>
  <condition>Cardiac Resynchronization Therapy</condition>
  <condition>Reduced Biventricular Pacing</condition>
  <arm_group>
    <arm_group_label>Catheter ablation group</arm_group_label>
    <description>Patients with reduced biventricular pacing due to PVC or VT receiving catheter ablation of PVC/VT according to guidelines and clinical practices</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medical treatment group</arm_group_label>
    <description>Patients with reduced biventricular pacing due to PVC or VT receiving intensified medical therapy (antiarrhythmics/betablocker) according to guidelines and clinical practices</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Catheter ablation of ventricular arrhythmia</intervention_name>
    <description>PVC or VT ablation</description>
    <arm_group_label>Catheter ablation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intensified medical therapy</intervention_name>
    <description>Dosage increase / new onset of Betablocker / medical antiarrhythmic medication according to guideline and clinical practice</description>
    <arm_group_label>Medical treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pts. with systolic heart failure, wide QRS complex and CRT with reduced biventricular&#xD;
        pacing due to ventricular arrhythmia (PVC/VT)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  reduced biventricular pacing &lt;98% due to ventricular arrhythmia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  reduced biventricular pacing &lt;98% due to other cause&#xD;
&#xD;
          -  age &lt;18&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Cologne</name>
      <address>
        <city>Cologne</city>
        <state>NRW</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 16, 2019</study_first_submitted>
  <study_first_submitted_qc>August 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2019</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
    <mesh_term>Ventricular Premature Complexes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

